RSS

GNBTQ Generex Biotechnology Corp.

Mod: rjs9787 Asst: docj
Last Post: 10/16/26
Followers: 122
Posts Today: 0
Views Today: 5085

GNBTQ Stock Quote & Tools

$0.0000 ▲ +0.0000 (+0.00%) As of Jan 25, 4:00 PM
Last0.0000
$ Chg0.0000
Open—
High—
Beta0.5408
Year High—
Market Cap—
P/B Ratio-0.54
EPS—
Avg Vol (30d)0
Volume—
% Chg+0.00%
Prev Close0.0000
Low—
VWAP0.00000
Year Low—
Total Shares118.45M
Shares Out118.45M
Float116.37M
Exchange
Healthcare Biotechnology & Life Sciences

GNBTQ Stock Message Board Discussion

Top 10 Most Recent News Articles

Volvo's Q3 2026 Results: Strong Growth and Margin

Updated Category News Views 6

Volvo Group's Robust Q3 Performance It's not every day that you see a company like Volvo Group churning out results that make you take a second sip of that morning coffee. But here we are—looking at Q3 2026 with growth numbers that pack a punch. You can't argue with SEK 119.5 billion in net sales, especially when organic sales growth hit 7%. That's no small feat in...

Continue Reading
Supercar Buying: Key Factors to Verify First

Updated Category News Views 6

The Grind of Securing a Limited-Edition Supercar If you're grinding to buy one of those elusive limited-edition supercars, you'd better buckle up. According to Kendall Gath over at iLusso, this ain't like picking up groceries at the local market. There's a whole list of things to consider before you even think about handing over your wad of cash. Differentiating Fact from...

Continue Reading
Reel Drops: Eightpoint's New Social Drama App Explored

Updated Category News Views 4

Mobile Drama: A Quick Escape with Reel Drops In this fast-moving world, where time feels as elusive as a daydream, Eightpoint is shaking up mobile entertainment with its brand-new app, Reel Drops. Based out of George Town, Cayman Islands, this app aims to give viewers a shot at swift, captivating storytelling without the marathon commitment of a binge-watch session. A New...

Continue Reading
Cboe Clear's US Move: A New Chapter with SEC Nod

Updated Category News Views 4

Clearing the Path for New Beginnings The ink's barely dry on Cboe Clear U.S.'s recent SEC registration, and it's already setting tongues wagging among market old-timers. This move to clear binary securities options alongside futures isn't just a step up; it's a signal flare for ambitious innovation. The Nuts and Bolts: SEC Registration So, what's the big to-do? Cboe Clear...

Continue Reading
UCB's Endowment Marks New Era in Medicine Evaluation

Updated Category News Views 0

Stepping into a New Chapter for Medicine Evaluation UCB's latest move smacks of a strategic vision that's not just about immediate returns—it's a long game in pharmacoepidemiology. You don't see investors lining up for this news, but this chair at Brigham and Women's is bigger than it looks. By establishing the Emmanuel Janssen Endowed Chair, UCB is underpinning the...

Continue Reading
Concrete Admixtures Market: A Billion-Dollar Boom

Updated Category News Views 5

A Look Under the Hood of Concrete Admixtures It's a concrete jungle out there, folks—literally. The once overlooked market of concrete admixtures is gearing up for quite the makeover, projected to hit USD 35.87 billion by 2035. For those of you tuning in, we're talking about chemicals that mix into your average concrete to change its properties. And, believe it or not,...

Continue Reading
Gentex Shares Tumble Amid Legal Investigation Concerns

Updated Category News Views 0

Gentex's Financial Outlook Takes a Hit Well, here we are again, catching another corporate hiccup. Gentex Corporation, or as ticker hounds know it, NASDAQ:GNTX, just pulled the rug out from its investors by chopping the top off its 2026 revenue guidance. Dropping to a floor it once considered a ceiling, $2.65 billion is now the most optimistic number they're pitching. No...

Continue Reading
FDA Nod for Subcutaneous SKYRIZI in Crohn's Disease

Updated Category News Views 0

AbbVie's Injection Makes Waves in Crohn's Treatment Here's a bit of medicine shake-up for you. AbbVie just snagged FDA approval for its subcutaneous SKYRIZI—specifically designed for adults battling moderately to severely active Crohn's disease. This news isn't just a blip on the radar; it's significant for patients and the healthcare landscape. We're talking about new...

Continue Reading
First Citizens Surprises with Q3 Gains and Buyback Plan

Updated Category News Views 5

Unexpected Third Quarter Tailwinds for First Citizens There are days in this trading gig when a bank I'll barely sneeze at hits out of the park. First Citizens BancShares (NASDAQ:FCNCA) pulled off such a feat, wringing out a third-quarter 2026 performance that beat their own benchmarks. They threw $600 million back to shareholders in repurchased stocks while repaying an...

Continue Reading
Amazon OIL9 Drivers Join Teamsters, Demand Better Pay

Updated Category News Views 4

Amazon's OIL9 Facility Faces Union Uprising Never a dull moment with Amazon, is there? Just when you think you've seen it all in the labor struggle world, drivers at Amazon's OIL9 facility in Merrillville, Indiana, decide to join the Teamsters. These folks are not just making deliveries; they're laying down the battle lines, demanding Amazon acknowledge their union and...

Continue Reading

Top 5 Most Recently Viewed Articles

Wolters Kluwer Launches Innovative User Conference in Vegas

Updated Category News Views 225

Wolters Kluwer Launches Innovative User Conference in Vegas Wolters Kluwer Tax & Accounting (TAA) is gearing up for a monumental event—its 20th annual CCH Connections: User Conference. This year, the exciting conference will be taking place next week in Las Vegas, attracting more than 1,400 professionals in tax, accounting, and auditing. Attendees can expect engaging...

Continue Reading
ADGM Stock Falls to Record Low: Overview of Market Factors

Updated Category News Views 198

ADGM Stock Hits 52-Week Low Amid Market Challenges The stock of ADGM Inc. has recently reached a concerning milestone, touching a 52-week low of $1.62. This downturn in value reflects the increasing caution among investors as they navigate through a tumultuous economic environment. Despite showing a beta of -0.09, which indicates a tendency to operate independently of...

Continue Reading
Qorvis Enhances Middle East Operations with New Offices

Updated Category News Views 194

Qorvis Strengthens Its Presence in the Middle East Qorvis, a prominent global strategic communications and advisory firm, has taken significant steps to enhance its operations in the Middle East. This comes with the establishment of a new subsidiary in Riyadh and the expansion of its regional headquarters located in the Almas Tower in the Dubai Multi Commodities Centre...

Continue Reading
AXA S.A. Receives Strong Ratings from AM Best for 2024

Updated Category News Views 378

AXA S.A. got a solid thumbs-up from AM Best back in 2023, locking down an A+ (Superior) Financial Strength Rating and 'aa-' Long-Term Issuer Credit Ratings. But what does that really mean for traders eyeing the insurance space? Sure, it looks good on paper—ratings reflecting stability—but these affirmations come with some caveats that can’t be ignored. Financial...

Continue Reading
Mallinckrodt's Potential Merger with Endo: Key Developments

Updated Category News Views 226

Mallinckrodt's Envisioned Merger with Endo Mallinckrodt plc, a leading global specialty pharmaceutical company, has made striking advancements in its proposed merger with Endo International plc. This significant event in the pharmaceutical industry not only showcases the evolving dynamics between two healthcare giants but also promises to create new opportunities for...

Continue Reading